Oseltamivir phosphate 75MG capsules (NDC: 47781-470-13); 10 CT. Blisters packs and oseltamivir phosphate 30MG capsules (NDC: 47781-468-13); 10 CT. Blisters packs.

Active Awarded Last action

Contract number
75A50325F80013
Awardee
Awarding agency
Obligated
$227,679,090

Award facts

Opportunity
  • 75A50325Q00001 Solicitation number
Contract value 100% obligated
$227,679,090.00 Current and potential, with all options
Completion date 66% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Pine Brook, Montville, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $227,679,090

About this award

This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Alvogen, Inc., a pharmaceutical manufacturer based in Morristown, New Jersey. The contract is for the delivery of 75mg and 30mg oseltamivir phosphate capsules, also known as the antiviral drug Tamiflu, to support the Strategic National Stockpile. The total ceiling value of the contract is $227,679,090.00, and it has an ultimate completion date of June 29, 2027. This contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside designation.

Quick answers

Who was awarded contract 75A50325F80013?

75A50325F80013 was awarded to Alvogen, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on June 30, 2025.

How much is contract 75A50325F80013 worth?

The government has obligated $227,679,090 on 75A50325F80013.

Is contract 75A50325F80013 an order under another contract?

Yes. 75A50325F80013 is a delivery order under V797D70134, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75A50325F80013 competed?

The extent of competition for 75A50325F80013 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award